Company Filing History:
Years Active: 2007
Title: Max Custer: Innovator in Hantavirus Research
Introduction
Max Custer is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of infectious diseases, particularly through his innovative work on protective DNA vaccines against hantaviruses. His research has implications for public health and safety.
Latest Patents
Max Custer holds a patent for an extraneous DNA sequence that facilitates hantavirus gene expression. This patent describes a protective DNA vaccine designed to combat infections associated with Hantaan virus and Hantavirus pulmonary syndrome. The vaccine was developed by subcloning cDNA that encodes the G1 and G2 glycoproteins into the DNA expression vector pWRG7077. Animals vaccinated with this construct demonstrated a robust neutralizing antibody response. Furthermore, passive transfer experiments indicated that serum from vaccinated animals could protect against lethal disease when administered shortly after exposure.
Career Highlights
Throughout his career, Max Custer has worked with the U.S. Government, specifically represented by the Secretary of the Army, and the U.S. Army Medical Research Institute of Infectious Diseases. His work has been pivotal in advancing the understanding and prevention of hantavirus infections.
Collaborations
Max has collaborated with esteemed colleagues such as Jay Hooper and Connie S. Schmaljohn. Their combined expertise has contributed to the success of his research initiatives.
Conclusion
Max Custer's innovative work in developing DNA vaccines against hantaviruses showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against infectious diseases.